407 related articles for article (PubMed ID: 16995940)
21. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
[TBL] [Abstract][Full Text] [Related]
22. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.
Zavodna K; Bujalkova M; Krivulcik T; Alemayehu A; Skorvaga M; Marra G; Fridrichova I; Jiricny J; Bartosova Z
Neoplasma; 2006; 53(4):269-76. PubMed ID: 16830052
[TBL] [Abstract][Full Text] [Related]
23. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
[TBL] [Abstract][Full Text] [Related]
24. [Mutation analysis of hMSH2 and hMLH1 genes in Chinese hereditary nonpolyposis colorectal cancer families].
Cai Q; Sun MH; Fu G; Ding CW; Mo SJ; Cai SJ; Ren SX; Min DL; Xu XL; Zhu WP; Zhang TM; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):323-8. PubMed ID: 14514376
[TBL] [Abstract][Full Text] [Related]
25. Genetics of hereditary nonpolyposis colorectal cancer.
Akrami SM
Arch Iran Med; 2006 Oct; 9(4):381-9. PubMed ID: 17061614
[TBL] [Abstract][Full Text] [Related]
26. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers.
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Am J Hum Genet; 2003 Nov; 73(5):1157-61. PubMed ID: 14526391
[TBL] [Abstract][Full Text] [Related]
27. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
[TBL] [Abstract][Full Text] [Related]
28. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
Balmaña J; Stockwell DH; Steyerberg EW; Stoffel EM; Deffenbaugh AM; Reid JE; Ward B; Scholl T; Hendrickson B; Tazelaar J; Burbidge LA; Syngal S
JAMA; 2006 Sep; 296(12):1469-78. PubMed ID: 17003395
[TBL] [Abstract][Full Text] [Related]
29. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
[TBL] [Abstract][Full Text] [Related]
30. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
31. Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds.
Nyström-Lahti M; Holmberg M; Fidalgo P; Salovaara R; de la Chapelle A; Jiricny J; Peltomäki P
Genes Chromosomes Cancer; 1999 Dec; 26(4):372-5. PubMed ID: 10534773
[TBL] [Abstract][Full Text] [Related]
32. High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.
Martínez-Bouzas C; Ojembarrena E; Beristain E; Errasti J; Viguera N; Tejada Minguéz MI
Cancer Lett; 2007 Oct; 255(2):295-9. PubMed ID: 17582678
[TBL] [Abstract][Full Text] [Related]
33. Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2.
Genuardi M; Carrara S; Anti M; Ponz de Leòn M; Viel A
Eur J Hum Genet; 1999; 7(7):778-82. PubMed ID: 10573010
[TBL] [Abstract][Full Text] [Related]
34. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.
Quehenberger F; Vasen HF; van Houwelingen HC
J Med Genet; 2005 Jun; 42(6):491-6. PubMed ID: 15937084
[TBL] [Abstract][Full Text] [Related]
35. Site directed mutagenesis of hMLH1 exonic splicing enhancers does not correlate with splicing disruption.
Lastella P; Resta N; Miccolis I; Quagliarella A; Guanti G; Stella A
J Med Genet; 2004 Jun; 41(6):e72. PubMed ID: 15173238
[No Abstract] [Full Text] [Related]
36. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.
Arnold S; Buchanan DD; Barker M; Jaskowski L; Walsh MD; Birney G; Woods MO; Hopper JL; Jenkins MA; Brown MA; Tavtigian SV; Goldgar DE; Young JP; Spurdle AB
Hum Mutat; 2009 May; 30(5):757-70. PubMed ID: 19267393
[TBL] [Abstract][Full Text] [Related]
37. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.
Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK
Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996
[TBL] [Abstract][Full Text] [Related]
38. Pathological exon skipping in an HNPCC proband with MLH1 splice acceptor site mutation.
Clarke LA; Veiga I; Isidro G; Jordan P; Ramos JS; Castedo S; Boavida MG
Genes Chromosomes Cancer; 2000 Dec; 29(4):367-70. PubMed ID: 11066084
[TBL] [Abstract][Full Text] [Related]
39. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
40. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
